Chronic asthma Flashcards
Symptoms
- Dyspnoea
- Chest tightness
- Wheezing
- Cough
- Symptoms typically happen more at night when asleep
Triggers
- Infection
- Hay fever
- Dust
- Pets
- Smoking
- Chemicals
- Medication: NSAID + Beta blocker
Treatment: BTS/SIGN guidelines: adults + 12+
Offer SABA prn
→ Regular preventer: low dose ICS
→ Initial add on therapy: LABA (fixed dose or MART)
→ Additional controller therapies:
- (if no response to LABA consider stopping)
- Medium dose ICS OR
- LTRA
→ Refer patient for special care (oral steroid, theophylline)
Reasons to step up treatment: BTS/SIGN guidelines: adults + 12+
- Taking 3 doses a week/more
- Night time waking once a week
- Asthma attack that needed oral steroids in the last 2 years
URGENT assess if >1 inhaler a month
Low dose ICS: adults
- Beclometasone: 200-400mcg
- Budesonide: 400mcg
- Fluticasone: 200mcg
- Mometasone: 400mcg
- Ciclesonide: 160mcg
Drugs
- SABA: salbutamol, terbutaline
- LTRA: montelukast
- LABA: formoterol, salmeterol
- Oral steroid prednisolone
Low dose ICS: children
- Beclomethasone: 200-400mcg
- Fluticasone: 200mcg
SABA: MOA
Acts on B2-adrenoreceptor on bronchi = bronchodilation for 3-5H
SABA: indication
reliever inhaler
- Asthma
- COPD
SABA: Dose
2 puffs QDS PRN
- Counsel: take dose immediately before exercise to prevent symptoms
- Counsel: see doctor if dose fails to provide relief <3H
SABA: Side effect
Hypokalaemia
- Caution: diuretics, hypoxia
- Monitor:
- Potassium: severe asthma + COPD
- Glucose: diabetes
Hand tremors
CVS effects
LABA: MOA
Acts on B2-adrenoreceptors on bronchi = bronchodilation for 12H
LABA: drugs
- Formoterol (BD: short onset reliever (fostair - fridge))
- Salmeterol (BD: long onset)
- Vilanterol (OD: combination inhaler with fluticasone)
- Olodaterol + indacaterol (OD: COPD only)
LABA: indication
not used alone, taken with ICS
Asthma (w regular ICS)
- Add only if ICS fail
- Stop if no benefit, step down when good control
- Not for exercise induced asthma unless on regular ICS
- Do not start in rapidly deteriorating asthma
COPD
LABA: combination inhalers rationale
- Stable dose
- Minimise no. of inhalers
- Improves compliance
- Guarantees ICS
LABA: dose
Twice daily (+ reliever doses if MART)
- Counsel: report any deterioration after starting a LABA